Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harbor vs Henry Meds

Harbor
Graded #87

Lower grade

vs+5.5
Henry Meds
Graded #46

Higher grade

The verdict

Henry Meds takes it — 77.3/100 to 71.8/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHarbor +1
73
72
Dose & formulationHenry Meds +16
64
80
Clinical oversightHarbor +9
89
80
Labs & monitoringHenry Meds +15
63
78
FulfillmentHarbor +3
81
78
Contract termsHenry Meds +31
47
78
Harbor · left barHenry Meds · right bar

The numbers

MetricHarborHenry Meds
WeighScore71.8/10077.3/100
GradeCC+
Scorecard rank#87#46
Semaglutide$99/mo (starting dose, compounded)$249/mo
Tirzepatide$149/mo (starting dose, compounded)$349/mo
CoverageCoverage not publishedMulti-state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Harbor

Graded #87 · C

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

Where it loses points

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified
Henry Meds

Graded #46 · C+

Strengths

  • Simple flat-fee model
  • Established brand
  • Both molecules

Where it loses points

  • Higher pricing than newer entrants
  • Compounded only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard